KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMode (INMD) Total Non-Current Liabilities (2018 - 2026)

InMode's Total Non-Current Liabilities history spans 9 years, with the latest figure at $12.2 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 3.3% to $12.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $12.2 million, a 3.3% decrease, with the full-year FY2025 number at $12.5 million, up 4.03% from a year prior.
  • Total Non-Current Liabilities hit $12.2 million in Q1 2026 for InMode, down from $12.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for INMD hit a ceiling of $13.4 million in Q2 2025 and a floor of $7.0 million in Q1 2023.
  • Historically, Total Non-Current Liabilities has averaged $11.0 million across 5 years, with a median of $11.8 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 64.94% in 2022 and later plummeted 42.0% in 2023.
  • Tracing INMD's Total Non-Current Liabilities over 5 years: stood at $7.8 million in 2022, then skyrocketed by 51.56% to $11.8 million in 2023, then increased by 1.91% to $12.0 million in 2024, then grew by 4.03% to $12.5 million in 2025, then dropped by 2.05% to $12.2 million in 2026.
  • Business Quant data shows Total Non-Current Liabilities for INMD at $12.2 million in Q1 2026, $12.5 million in Q4 2025, and $12.9 million in Q3 2025.